Silk Road Medical Inc (NASDAQ: SILK) stock jumped 3.53% on Friday to $8.50 against a previous-day closing price of $8.21. With 1.05 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.3 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $8.64 whereas the lowest price it dropped to was $8.15. The 52-week range on SILK shows that it touched its highest point at $58.04 and its lowest point at $6.08 during that stretch. It currently has a 1-year price target of $11.57. With its current market cap of 331.08 million, SILK has annualized dividend of $0.13 while the current yield stands at 1.52%. Beta for the stock currently stands at 1.32.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SILK was up-trending over the past week, with a rise of 23.73%, but this was up by 22.13% over a month. Three-month performance dropped to -60.70% while six-month performance fell -72.39%. The stock lost -83.80% in the past year, while it has lost -83.92% so far this year. A look at the trailing 12-month EPS for SILK yields -1.44 with Next year EPS estimates of -1.47. For the next quarter, that number is -0.41. This implies an EPS growth rate of 1.77% for this year and 2.89% for next year. EPS is expected to grow by 16.20% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -19.50%.
Float and Shares Shorts:
At present, 38.36 million SILK shares are outstanding with a float of 36.33 million shares on hand for trading. On Oct 30, 2023, short shares totaled 2.54 million, which was 6.53% higher than short shares on Sep 28, 2023. In addition to Mr. Lucas W. Buchanan as the firm’s CFO & COO, Mr. Kevin M. Klemz serves as its EVP, Chief Legal Officer & Secretary.
Through their ownership of 115.79% of SILK’s outstanding shares, institutional investors have majority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SILK since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SILK analysts setting a high price target of $25.00 and a low target of $8.00, the average target price over the next 12 months is $11.57. Based on these targets, SILK could surge 194.12% to reach the target high and fall by -5.88% to reach the target low. Reaching the average price target will result in a growth of 36.12% from current levels.
Summary of Insider Activity:
Insiders traded SILK stock several times over the past three months with 6 Buys and 1 Sells. In these transactions, 466,329 shares were bought while 656 shares were sold. The number of buy transactions has increased to 53 while that of sell transactions has risen to 44 over the past year. The total number of shares bought during that period was 838,238 while 329,244 shares were sold.